AU699055B2 - Process for making liposome preparation - Google Patents

Process for making liposome preparation

Info

Publication number
AU699055B2
AU699055B2 AU60365/96A AU6036596A AU699055B2 AU 699055 B2 AU699055 B2 AU 699055B2 AU 60365/96 A AU60365/96 A AU 60365/96A AU 6036596 A AU6036596 A AU 6036596A AU 699055 B2 AU699055 B2 AU 699055B2
Authority
AU
Australia
Prior art keywords
portions
liposome
lipid
encapsulated
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU60365/96A
Other languages
English (en)
Other versions
AU6036596A (en
Inventor
Carl L. Alving
Roberta R. Owens
Nabila M. Wassef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of the Army
Original Assignee
United States Department of the Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23888222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU699055(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by United States Department of the Army filed Critical United States Department of the Army
Publication of AU6036596A publication Critical patent/AU6036596A/en
Application granted granted Critical
Publication of AU699055B2 publication Critical patent/AU699055B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AU60365/96A 1995-06-07 1996-06-06 Process for making liposome preparation Ceased AU699055B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/475,581 US6007838A (en) 1995-06-07 1995-06-07 Process for making liposome preparation
US08/475581 1995-06-07
PCT/US1996/008622 WO1996040063A1 (en) 1995-06-07 1996-06-06 Process for making liposome preparation

Publications (2)

Publication Number Publication Date
AU6036596A AU6036596A (en) 1996-12-30
AU699055B2 true AU699055B2 (en) 1998-11-19

Family

ID=23888222

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60365/96A Ceased AU699055B2 (en) 1995-06-07 1996-06-06 Process for making liposome preparation

Country Status (12)

Country Link
US (1) US6007838A (cg-RX-API-DMAC7.html)
EP (1) EP0831779B2 (cg-RX-API-DMAC7.html)
JP (1) JP2000514035A (cg-RX-API-DMAC7.html)
AT (1) ATE203898T1 (cg-RX-API-DMAC7.html)
AU (1) AU699055B2 (cg-RX-API-DMAC7.html)
CA (1) CA2223808A1 (cg-RX-API-DMAC7.html)
DE (1) DE69614385T3 (cg-RX-API-DMAC7.html)
DK (1) DK0831779T4 (cg-RX-API-DMAC7.html)
ES (1) ES2159358T3 (cg-RX-API-DMAC7.html)
IL (1) IL122486A (cg-RX-API-DMAC7.html)
PT (1) PT831779E (cg-RX-API-DMAC7.html)
WO (1) WO1996040063A1 (cg-RX-API-DMAC7.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752802C (en) * 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
DE60130440D1 (de) 2000-03-21 2007-10-25 Suzanne Jaffe Stillman Aufgussbeutel mit dekorativen gebrauchsmitteln, trägerelementen, abgabevorrichtung und verfahren
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
US6852323B2 (en) 2000-07-21 2005-02-08 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
EP1519714B1 (en) 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
JP2006508126A (ja) * 2002-11-06 2006-03-09 アザヤ セラピューティクス インコーポレイティッド 薬学的製剤のタンパク質安定化されたリポソーム製剤
JP5639338B2 (ja) 2005-07-27 2014-12-10 プロチバ バイオセラピューティクス インコーポレイティッド リポソームの製造システムおよび製造方法
WO2007049279A2 (en) * 2005-10-26 2007-05-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem A liposomal combination and uses thereof
ES2337309T5 (es) 2006-06-12 2013-07-30 Glaxosmithkline Biologicals S.A. Vacuna
NO329127B1 (no) * 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
EP2427243A4 (en) 2009-05-05 2012-11-21 Vapogenix Inc NEW FORMULATIONS OF VOLATILE ANESTHETICS AND METHOD OF ADMINISTRATION
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
PL2968214T3 (pl) 2013-03-15 2021-11-02 Newvapogen, Inc. Nowe kompozycje przeciwbólowe
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
PL3615005T3 (pl) 2017-04-28 2025-10-06 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Kompozycje i sposoby dostarczania szczepionki
CN114126600B (zh) * 2020-01-20 2024-03-08 广州谷森制药有限公司 三苯乙酸维兰特罗的脂质体制剂
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004592A1 (en) * 1986-02-10 1987-08-13 Liposome Technology, Inc. Controlled-release liposome delivery system
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) † 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
US4752425A (en) † 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US5631237A (en) † 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
FR2714601B1 (fr) † 1993-12-30 1996-02-09 Oreal Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004592A1 (en) * 1986-02-10 1987-08-13 Liposome Technology, Inc. Controlled-release liposome delivery system
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung

Also Published As

Publication number Publication date
EP0831779B2 (en) 2005-01-19
EP0831779A1 (en) 1998-04-01
WO1996040063A1 (en) 1996-12-19
IL122486A0 (en) 1998-06-15
PT831779E (pt) 2001-11-30
EP0831779B1 (en) 2001-08-08
ES2159358T3 (es) 2001-10-01
JP2000514035A (ja) 2000-10-24
CA2223808A1 (en) 1996-12-19
DE69614385T2 (de) 2002-05-23
IL122486A (en) 2000-07-16
AU6036596A (en) 1996-12-30
DE69614385T3 (de) 2005-05-25
DK0831779T3 (da) 2001-10-08
US6007838A (en) 1999-12-28
DK0831779T4 (da) 2005-06-06
ATE203898T1 (de) 2001-08-15
DE69614385D1 (de) 2001-09-13

Similar Documents

Publication Publication Date Title
EP0831779B2 (en) Process for making liposome preparation
US6322809B1 (en) Liposomes containing particulate materials
EP0812209B1 (en) Cochleate delivery vehicles for biologically relevant molecules
US4199565A (en) Liposome particle containing viral or bacterial antigenic subunit
US4235871A (en) Method of encapsulating biologically active materials in lipid vesicles
US4201767A (en) Viral liposome particle
US20050037086A1 (en) Continuous-flow method for preparing microparticles
EP0537326A1 (fr) Vecteur de delivrance d'arn
JPH04500203A (ja) インフルエンザワクチンおよび新規なアジュバント
CN1044093C (zh) 低毒性药物类脂制剂
DK165220B (da) Liposomsammensaetninger indeholdende syntetiske phospholipider og et farmaceutisk aktivt stof samt deres fremstilling og phospholipidblanding til fremstilling af sammensaetningerne
AU783918B2 (en) Continuous-flow method for preparing microparticles
CN1479609A (zh) 肽的经口递送
JP2005529086A (ja) 精製大豆ホスファチジルセリンによって作製される渦巻状物
JPS6362490B2 (cg-RX-API-DMAC7.html)
WO1990003808A1 (en) Heat treating liposomes
EP1237541B1 (en) Liposomes comprising a complex of a polyanionic compound and calcium phosphate
CN115998706A (zh) 靶向负载aie及万古霉素的脂质体微泡复合物制备方法及应用
WO1996040243A1 (en) Liposomes containing human immunodeficiency virus glycoprotein and methods for use thereof
EP0559698A1 (en) Methods of immobilizing liposomes in gel beads and similar materials, gel beads and similar materials with immobilized liposomes prepared by such methods and uses thereof
CA2173601C (en) Liposomes containing particulate materials
RU2600031C2 (ru) Лекарственная форма специфического иммунобиологического лекарственного средства для лечения и профилактики вич инфекции и способ ее получения
WO1999000142A1 (en) Method for inducing a systemic immune response to a hepatitis or hiv antigen